Legal Opinion
Concordia Pharmaceuticals, Inc. v. Method Pharmaceuticals, LLC
District Court, W.D. Virginia
Decided March 2, 2017No. Civil Action No. 3:14CV00016PublishedCited by 5 opinions
1Opinion of the Court
MEMORANDUM OPINION
Glen E. Conrad, Chief United States District Judge
On the fourth day of a bifurcated trial, a jury returned a verdict in favor of the plaintiff, Concordia Pharmaceuticals, Inc: (“Concordia”), on its claim that the defendants, Method Pharmaceuticals, LLC (“Defendant Method”) and Matthew Scott Tucker (“Defendant Tucker, and collectively, “Method”), engaged in false advertising in violation of the Lanham Act, 15 U.S.C. § 1125(a)(1)(B). In the subsequent damages phase of trial, the jury found that Concordia was entitled to $733,200.00 in actual or compensatory damages. .However,…
2Cases cited15 opinions
- Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
- The Perkin-Elmer Corporation, a Corporation of New York v. Computervision Corporation, a Corporation of DelawareCourt of Appeals for the Federal Circuit · 1984
- Octane Fitness, LLC v. ICON Health & Fitness, Inc.Supreme Court of the United States · 2014
- Zazu Designs, a Partnership v. L'oreal, S.A.Court of Appeals for the Seventh Circuit · 1992
- Badger Meter, Incorporated, Cross-Appellee v. Grinnell Corporation and Mueller CompanyCourt of Appeals for the Seventh Circuit · 1994
10 more not listed; retrieve them via the Exa API.
3Cited by5 opinions
- Beyond, Inc. v. The Asset Store, LLCDistrict Court, D. Maryland · 2025
- Hayward Industries, Inc. v. BlueWorks CorporationDistrict Court, W.D. North Carolina · 2025
- Makina ve Kimya Endustrisi Kurumu v. KayaDistrict Court, W.D. Virginia · 2024
- Marriott International, Inc. v. Dynasty Marketing Group LLCDistrict Court, E.D. Virginia · 2024
- Mission1st Group, Inc. v. Mission First Solutions, LLCDistrict Court, E.D. Virginia · 2024